Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND studyYoshikazu Kinoshita, Motoyasu Kusano, Mitsuhiro Fujishiro et al.|Journal of Gastroenterology|2017Cited by 30